These results, together with a former report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the idea of targeting ACKR3 as a singular way to modulate the opioid method, which could open new therapeutic avenues for opioid-linked Diseases.A investigate analyze published in Anesthesiology and